Revolutionizing Breast Cancer Prevention: The Promising Vaccine Journey

In this exclusive interview, we dive into the groundbreaking world of breast cancer prevention with a potential game-changing vaccine. Join us as we talk with Jennifer Davis, the first patient in the word to receive the breast cancer vaccine, and Dr. Amit Kumar with ANIXA, the pioneering company behind this cutting-edge technology. Discover the vaccine’s mechanism, its potential to prevent breast cancer recurrence, and the profound impact it could have on women’s lives worldwide. This compelling conversation sheds light on hope, advancements, and the journey to a cancer-free future. Don’t miss this life-changing discussion! #breastcancer #breastcancervaccine #breastcancertreatment https://anixa.com

(The following transcript was auto-generated and might contain some errors.)

00:00:00:03 – 00:00:06:01

The first. Let’s talk about the vaccine itself. What what is it? What is it called? What is the actual name of this vaccine?

00:00:06:21 – 00:00:17:05

Well, right now we have in place to trade name on it. We just call it the breast cancer or breast cancer vaccine. Okay. And it says breast cancer vaccine for now.

00:00:17:13 – 00:00:33:00

Okay, Fair enough. And what is the actual goal of this vaccine? Is it to cure breast cancer? Is it to prevent breast cancer from recurring, from happening in the first place? Walk me through a little bit of what the actual goal of this medicine is.

00:00:33:16 – 00:00:59:16

Yeah, the goal is to prevent breast cancer. Initially, in women who have already survived breast cancer. And we’re initially focused on triple negative breast cancer, which is the most lethal form of breast cancer. And the goal is to prevent it in cancer survivors and then eventually to prevent it coming on in the first place. In women who’ve never had breast cancer.

00:01:00:15 – 00:01:08:11

Gotcha. So it would actually be a prophylactic, correct? I think we don’t we don’t have anything, anything remotely like that.

00:01:09:03 – 00:01:19:02

That is correct. Not certainly not for breast cancer. We do for cervical cancer. But besides that, really no other cancers.

00:01:19:11 – 00:01:28:02

Okay. And then who is it? At present, you just you should just stand at a future goal. But our president, who is this vaccine intended for? And how does it work?

00:01:29:07 – 00:01:56:01

Yeah, so initially we are testing it on women like Jennifer who have had breast cancer, specifically triple negative breast cancer, and have gone through standard of care. And now we are hoping to prevent the recurrence of that cancer in those women. And we’ve just begun to trial it. So we’ve tested it on 15 women so far, and the data is looking very good.

00:01:57:04 – 00:02:26:01

Now, the way this this vaccine works is that our bodies produce proteins at certain times for specific functions, and then after that function is no longer necessary, the body stops making that protein. If if it’s a protein that is only specific for that function. And in the case of breast cancer, there’s a lactation protein. It’s called alpha left albumin.

00:02:27:09 – 00:02:52:21

And the name is not necessarily that important, but it’s a protein that is produced in women’s breast. When a woman gives birth. So what the body tells the tells the breast cells, the mammary gland cells is we just gave birth. We need to produce mother’s milk. And, you know, as you know, most breast don’t produce milk all the time.

00:02:53:06 – 00:03:27:21

But when a woman gives birth, the body produces this protein called alpha lockdown. Women and alpha like albumin enables the production of milk so that the woman can breastfeed the child. But once the breastfeeding stops, the body says, We don’t need this protein anymore, so let’s stop making it and the protein disappears. Okay. However, the discovery that was made was that when cancer cells arise later on in life, those cancer cells start making this protein again.

00:03:28:05 – 00:04:05:19

We don’t know why cancer cells typically don’t follow the rules, and in this case, they start making that protein. So an immunologist named Vincent Tuohy at the Cleveland Clinic two decades ago hypothesized that if we could train a woman’s immune system after she’s done bearing all her children, train that immune system to destroy any cell making that protein, then the only cells in the future that are going to make that protein are breast cancer cells.

00:04:06:07 – 00:04:41:01

And if the immune system is properly vaccinated and trained to destroy those cells, then when breast cancer cells arise and, you know, breast cancer or any cancer typically arises out of one bad cell, it becomes two and four, eight, 16, and eventually becomes a multibillion cell mass that you can see in a mammogram. But if we could train the immune system to destroy those cells as they occur, then when the cells are at a for, you know, when the cancer is at a force cell, eight cells, 16 cells, phage immune system will destroy them.

00:04:41:01 – 00:05:05:10

And the cancer never has a chance to become a tumor. And so that’s the basic premise. And we proved that in animals. In fact, it was very, very successful in animals. We were able to prevent cancer in 100% of the animals that were needed. And now we’re in the human phase. We are testing this technology to see if we can prevent breast cancer in women.

00:05:05:20 – 00:05:35:02

And as I noted, we’ve only done tested it on 15 women so far. Eventually, before this this vaccine is available for the general public, we’ll have to have tested it on thousands of women. But so far, the data looks very good, very promising. And we’re very excited that we think we can not only prevent triple negative breast cancer, which is the most lethal form of breast cancer, but we also feel that eventually we’ll be able to prevent all types of breast cancer.

00:05:35:19 – 00:05:47:16

Unbelievable. So there’s a little bit of a layman’s question. I’m not I’m not a medical professional, obviously, but does the cancer feed on the alpha lactate albumin? Is that why?

00:05:48:14 – 00:06:25:01

No, it does not. Typically, what characterizes a cancer is uninhibited growth of the cell. And so the machinery of the cell has become disrupted and all of a sudden the cell machinery, the DNA and all the proteins within the cell start making even more proteins. So enabling the cell to reproduce uninhibited. And often when that process occurs, those cells start making every protein that they can think of that they ordinarily make, even though some of those proteins are not necessary.

00:06:25:08 – 00:06:53:22

So, for example, a woman who has these cancer cells that are making this lactation protein doesn’t lactate because that woman is no longer going to lactate, but the cells are making that protein and we don’t fully understand exactly all the details behind that. We just know phenomenal logically that the cells are making that protein. And so we just use that as a way to target those cells by the by the immune system.

00:06:54:04 – 00:07:27:12

It’s just like when we immunized people vaccinate people against an infectious disease like COVID or polio or something like that. What happens is when the COVID virus enters your body, the immune system has been properly vaccinated and it recognizes it and tries to destroy it before it can start reproducing dramatically and cause a major illness in you. This is the same principle, except it’s a cell’s protein, meaning it’s a protein made by the body.

00:07:27:12 – 00:07:38:19

It doesn’t come from outside the body, but we’ve taught the immune system to destroy the cells making that protein. So when that protein shows up, the immune system destroys it. And the.

00:07:38:19 – 00:07:51:14

Reason. That was my question. Yeah. Yeah. You just cleared up. So it basically it’s a flag. It says that this woman has no need for this protein. These cells are making them. So we’re going to attack those cells.

00:07:51:15 – 00:07:58:23

That’s right. It says to the immune system, I’m cancer, you know, And the immune system says, okay, I see that you’re cancer. I’m going to come and destroy you.

00:07:59:12 – 00:08:22:17

Brilliant. Jenny, you’ve been so patient and quiet over there. So I’m going to come to you for it for for a second and just want to make sure that I’ve I’ve covered these these initial questions and so now we’re going to get to your story. So if you can tell us just this, I mean, I can’t imagine the emotions that you went through this whole process from the beginning.

00:08:23:01 – 00:08:29:24

But if you just tell us how this journey started for you and what the process was like, just walk me through that kind of timeline, if you could.

00:08:30:15 – 00:08:59:19

Mm hmm. I really found a lump in my left breast in February of 2018, I had a mammogram followed by an ultrasound and a biopsy. That biopsy actually came back as negative. I continue to to feel the lump grow. Went for follow up visits. They did not re biopsy it right away. It wasn’t until September of 2018 that they did re biopsy it.

00:09:00:03 – 00:09:34:04

That’s when it came back that it was triple negative and then it was at that time that I decided to go to Cleveland Clinic and then that’s where my team was established and my plan of care was set. So my plan of care was start out with chemotherapy. I had four rounds of admission followed by what was supposed to be 12 rounds of Taxol that got a little bit short just because of the side effects that I was having.

00:09:35:22 – 00:10:01:02

Neuropathy was really, really bad. And of course, you know, when you’re getting treatment for something like this, you never want to stop because you think that’s what’s going to save your life. That’s what I thought. So that was very difficult. You know, the whole the whole journey was such a rollercoaster because you would have, you know, things would be going good and then things would not go so well throughout the entire span of the last five years, really.

00:10:02:18 – 00:10:25:08

But I was I was devastated when, you know, my oncologist said that he thought it was time to quit after seven rounds of the Taxol. Wow. I don’t know. And he just looked at me and said, I’m not here to hurt you. I’m here to help you. And you could end up in a wheelchair for the rest of your life if you continue on this and the neuropathy continues to progress.

00:10:25:21 – 00:10:50:07

So thankfully, I trusted my team and I think that’s a big takeaway that I have for all women. Find someone that you can, a team that you can trust because it’s so difficult going through all of this. So I did, I, I quit after seven and then had the double mastectomy, followed by 26 rounds of radiation after that.

00:10:51:07 – 00:10:59:21

Wow. Okay. So that was your your your initial treatment. How did you get involved in the actual trial then?

00:11:01:10 – 00:11:24:16

I said I was going to Cleveland Clinic. So again, that’s where all my follow ups were. I had follow up appointments and I still do every three months and with triple negative, there’s nothing that we take as far as a pill or any type of treatment that kind of says, you know what, this this cancer isn’t going to come back.

00:11:25:05 – 00:11:52:04

So am I triple negative. The recurrence rate is really high. And then if it does come back, prognosis isn’t the greatest. So it’s it’s a huge, huge worry. You know, it’s every day I was thinking that it had come back or is going to come back so going to my appointment. So I was looking for something. I was honestly desperate for whatever whatever they were coming up with.

00:11:52:22 – 00:12:11:19

And they had told me about the vaccine, but it wasn’t quite ready for the human face yet. And then it was just it just fell into place. I, I don’t know how or why it happened the way it did, but I ended up going in just for a regular appointment. And my nurse practitioner told me that it was ready.

00:12:11:19 – 00:12:31:19

It was ready for the human phase. There were some criteria that went along with that. I couldn’t be more than three years out from my first chemo treatment, and at that time I had to be cancer free. So there was a lot of testing and my window was very short, like a couple of weeks, or I was not going to qualify.

00:12:31:19 – 00:13:08:16

It was going to push me past my first chemo treatment date. So I was able to get all that testing done and they told me that I was going to be the first person to receive it. I was I didn’t worry about it, really. Like Doctor Kumar had told you, Doctor, too. We had studied this for 20 years, and the fact that they did not see any recurrence over a 20 year time span and there was no major side effects or anaphylactic reaction when this was given in the lab.

00:13:08:21 – 00:13:29:00

So those two things combined with if I get this and it prevents recurrence, and then on a grander scale, like if this could prevent triple negative breast cancer across the world, I was more than willing and I’m so thankful that I was able to receive it.

00:13:29:10 – 00:13:45:23

Amazing. Now, you said I was going to ask you, did you have any hesitations or doubts? And it seems like you did. What about your family and your support system? What was their reaction to? They freak out a little bit. Were they just like, Yeah, go for it? Like, tell me a little bit about that side of the story.

00:13:46:11 – 00:14:14:07

Yeah, my support system is huge. I’m married. I have three adult children. You know, my mom, my stepdad, my whole community. I live in a very small town. So everybody throughout the entire the entire thing was very, very supportive. But they were just as eager as I was, really. I mean, especially my mom, my husband always he was always so supportive and just, You’re fine.

00:14:14:08 – 00:14:34:23

You’re fine. This is fine. You’re going to be fine. He was I don’t know how he did it, but he was just able to really maintain that calm. My mom, you know, as I’m a mother. And I couldn’t imagine my mom going through what I did. And I can’t imagine my daughters going through what I did. So for her, it was an absolute rollercoaster.

00:14:35:12 – 00:14:52:14

She didn’t show a lot of that to me, but she was thrilled that I was getting it because she as well, you know, she didn’t want this to come back. And I have to go through all of that again. So so know everybody. They were cheerleaders. They were happy and excited for it.

00:14:52:14 – 00:15:00:19

Very cool that, you know, and when you start the actual treatment with with this vaccine, what did you do?

00:15:01:11 – 00:15:26:04

So, like I told you, it was a real short window. I had an appointment in September of 2021, and then my first dose of the vaccine was October 19th of 21. And so I received three doses two weeks apart, and there was lab work done prior to each appointment. And then there were two follow up appointments related to the vaccine where it was just lab work.

00:15:27:21 – 00:15:33:02

And then the results of that did not come out until April of this year.

00:15:34:05 – 00:15:52:16

Okay. So only three doses, but a year and a half ago, if my math is correct, that’s to ask the doctor, will there be more treatments or is this kind of it for for for this protocol.

00:15:53:03 – 00:16:27:11

For for Jenny? That’s it. That’s know when we hope that this vaccine will prevent recurrence of breast cancer for the rest of her life and and then the other 15, 14 women that we’ve created so far as we go forward, we will have to test this vaccine in larger numbers of women, eventually culminating in what’s known as a phase three trial, in which case we will vaccinate a number of women and then give a placebo to a similar number of women.

00:16:27:21 – 00:17:05:17

And then we will watch the incidence of cancer in the vaccinated group versus the placebo group. And the ratio of those numbers will determine how effective this vaccine is. And we’re hoping it’ll be 100% effective. But, you know, in biology, nothing is really 100% effective. But 60, 70, 80% or better is going to be spectacular. And, you know, one thing I should say really is, you know, Jenny talked about the anxiety about potentially taking a vaccine and she have indicated that she didn’t have any anxiety about taking the vaccine.

00:17:06:01 – 00:17:37:19

But the process of treating her breast cancer was a very brutal process. You know, many, many rounds of pre-surgery chemotherapy and then surgical, you know, the surgery itself, recovery, reconstruction and then post-surgery. She had multiple rounds of radiation, which causes burns. You know, it’s just not a sudden process. And even though we’ve gotten good, very good at catching breast cancer early, we teach women to do self-exams and then screenings.

00:17:38:07 – 00:18:00:14

And often we can treat it and save women’s lives. Not all the time, but more frequently than before. The process is very painful for a patient. It’s a very painful for everyone in that patient’s orbit. And, you know, our vision is to just give women the shot and then they never have to worry about it. I have I have breast cancer in my family.

00:18:00:22 – 00:18:29:00

I have two daughters. And I would love to be able to, you know, once approved, give this vaccine to them. And so they never have to worry about it. And, you know, you may know that there are also women who have high risk of breast cancer mutations in certain genes who are opting to have prophylactic mastectomy. So they’re getting their breasts removed while they’re completely healthy at the time because they don’t want to get breast cancer in the future.

00:18:29:06 – 00:18:45:14

And if they have their, you know, these key mutations, then chances are very high that they will. Angelina Jolie a few years ago was very famous for going public about her journey in that case. And what we’d like to do is just give them a shot. It’s a lot easier than having a surgery.

00:18:46:05 – 00:19:08:08

And yeah, and ease a lot of that that trauma because. Yeah. Wow. Unbelievable. Okay, so I know you’re very early in this process, but based on what you’ve seen so far, is anyone that you’re predicting shouldn’t be taking this any woman or any particular group of or class of women who I’m assuming anyone who wants to give birth?

00:19:08:18 – 00:19:37:08

That’s correct. You know, the vaccine is designed to destroy any cell that makes this alpha lactation. Alpha like to knock out the lactation protein. And so if we’ve, you know, based on the animal studies, what we found was that if we vaccinate an animal and let that animal give birth, what happens is that the baby is completely healthy in the in the mouse experiment.

00:19:37:08 – 00:20:05:21

But the mother doesn’t produce any more milk. And so the mouse that the infant is not able to feed. So and then give litters and the litters couldn’t even get milk. With humans, it’s different because with humans you can always feed them with formula, but we’re encouraging women not to take this vaccine until they’ve done they’ve completed giving, you know, giving birth.

00:20:06:04 – 00:20:31:08

If a woman decides that she wants to take this vaccine early because she has the mutations and she has not given birth yet, you know, that’s also possible. But we don’t want you know, that woman may want to, you know, choose to freeze some eggs or do something like that, because we don’t, you know, the animal studies showed that there that the infants were were perfectly healthy.

00:20:31:17 – 00:20:51:06

But we haven’t done those tests in humans and we don’t plan to do those tests. So the only thing we would encourage women not to take the vaccine if they’re still intending to or may decide to have children, because once you’re vaccinated and vaccinated, their immune system has been trained, you can’t take it back.

00:20:51:24 – 00:21:03:14

Right. Okay, good. Something to consider. Okay. Jennifer, did you experience any kind of side effects at all? I mean, I’m talking to as far as even like a burning or stinging or anything like that.

00:21:04:11 – 00:21:16:11

I had lumps at the injection injection sites. I had an injection in each leg and then one in my stomach and just bumps at the site. That was it. Nothing else.

00:21:16:18 – 00:21:30:21

Okay. Yeah. And we’ve done comprehensive testing to make sure all organ functions are fine. None of the patients had had fevers or anything serious besides the irritation of the injection sites.

00:21:31:19 – 00:21:42:24

Okay. So overall, Jenny, how has the experience of participating in this trial and receiving the vaccine affected your outlook on life and future?

00:21:46:07 – 00:22:08:02

I had a complete mind shift. You know, like I said, instead of waking up every morning and thinking my cancer came back or wondering if it will or every night before I go to bed thinking about the same thing, because it’s it was daily. Then I thought about those things because I had a headache. So I get a headache.

00:22:08:02 – 00:22:44:05

Now I take the Tylenol, go about my day. Like I don’t think that it is cancer that came back. So that in itself has been amazing to not have to worry about that every single day. And then just being able to realize what’s important in life. And then you you really do put things into perspective. And, you know, I, I changed how I feel about my work life and my home life and my family.

00:22:44:15 – 00:23:13:15

It all changed because what’s really important is them and spending time with them. And, you know, I never turn down a trip. I never turn down a dinner date, never turned down a good concert at this point. And I had told somebody else that I followed this guy. Jesse, it’s and he’s just inspirational and was helpful to me.

00:23:14:00 – 00:23:47:16

And the one thing he talks about is the only thing in life that can beat us. This is time. And I just have taken that to heart. And that’s that’s true. And he gives a perfect example, because I told you, my mom, my mom and I are very close. She’s my best friend. And, you know, he had talked about a little bit, you know, if you go on a trip one time a year with somebody or, you know, if you live far away from your parents or your best friend and you see them one time of year and, you know, you go on the average life expectancy in, let’s just say 80 for this purpose

00:23:47:16 – 00:23:50:11

sake, you know, and higher than that.

00:23:50:11 – 00:23:53:19

But it’s a nice round number, you know, even.

00:23:54:24 – 00:24:17:20

And so if you think about it like that and, you know, okay, well I’m let’s say 50 and round numbers and so then that would only mean 30 more times. 30 more times I get to see that person are 30 more trips. And to me that’s not enough. So I really take that time as I’m defeated to heart.

00:24:17:20 – 00:24:38:10

And I just try to I try to live a better life. I try to give back. I try to do all of those things. You know, nobody’s perfect. And I have my downfalls, too. But I really make the effort to to just be better. And I’m hopeful and full of all that good stuff.

00:24:38:23 – 00:24:54:08

Good. And you’re a pioneer now. You know, you’re the first you’re number one in this whole thing, which could actually revolutionize medicine and save the lives and improve the lives of many women. So very cool. I’m very blessed to be talking to you.

00:24:54:10 – 00:24:55:08

I’m healthy.

00:24:55:14 – 00:24:58:02

Yeah. Thank you. And you see, Doctor. And you, too.

00:24:58:15 – 00:25:20:07

And, you know, I. I want to highlight where you just said, you know, I say this a lot of times in my interviews and sometimes it gets and sometimes it doesn’t. But, you know, when when this vaccine eventually becomes available to the general public, it’s approved, which means it’s doing what we expect it to do. And it’s going to change medicine, as you said, it’s going to change culture.

00:25:20:07 – 00:25:49:20

I think it’s going to be a dramatic impact and there are going to be a lot of people that will get credit for it. You know, certainly again, Century, who is the inventor? People like myself and the physicians and nurses and doctors. But who are going to work on this, who have worked on this, who are going to work on this, but the people who are the pioneers in the most important constituents are people like Jenny, who are letting us test this vaccine on their bodies.

00:25:50:22 – 00:26:22:14

And and she is the pioneer. She’s the very first who took this very first human being who took this vaccine. And she has also applied for this, become a champion. A lot of people want to keep their medical information private. But she has spread the word and she said, hey, you know, I took this vaccine. I had breast cancer and I’m a big, you know, spokesperson for this vaccine and for women who are undergoing or may undergo breast cancer treatment.

00:26:22:22 – 00:26:43:14

So, yeah, so to speak to that, either one of you can answer this or both. But what’s been the reaction from other breast cancer survivors that you guys have talked to? Maybe Jenny can answer that first. When they hear about, you know, your experience and the potential for for this vaccine, what is their what is the feedback been and the reaction.

00:26:46:05 – 00:27:12:23

Almost 100% has been hope, like the fact that this is going to give a lot of people hope, survivors, you the hope is to get this vaccine and not have a recurrence and then be on that, like I said, for myself to be on that the grander scale as you know hope that triple negative and then other breast cancers will be eradicated from us from getting this vaccine.

00:27:12:23 – 00:27:47:09

So it’s been very, very positive. I’ve and I think that they just can’t wait to see, you know, honestly, their the reaction is, why can’t we speed it up? And as a patient, I could say that Dr. Mark can tell you, you know, we can’t. It’s research that has to be done, you know, and and that’s something I had to explain to my mom because she she couldn’t understand, you know, when she would watch some of these interviews or like look at the the data, she would say, well, why why can’t we just if this works?

00:27:47:22 – 00:28:15:06

Because we don’t really know yet if it works across the board, it’s looking like Dr. Kumar said, very promising. It has showed. Well, in the lab having the same results, you know, in this first phase here. So it’s great, but it’s just something that’s going to take a long time. And honestly, like in the grand picture, like it’s going to have to take my whole lifetime to to see if it works, to see if I have a recurrence.

00:28:15:17 – 00:28:26:16

But and that that that’s a little bit hard for people because they just want it to be available. They want their loved ones to get it. They want to get it. But the feedback has been wonderful.

00:28:27:10 – 00:28:38:14

Very good. Doctor, how soon do we expect this whole process to take before this hits the market, assuming everything goes, goes fine. You remember that so well?

00:28:38:22 – 00:29:00:15

That’s exactly right, says Jenny said It takes time and the US FDA, rightly so, doesn’t approve anything until it’s been tested on a significant number of patients based on the fact that a large, you know, multi millions of patients will be taking the billions of women we’re taking this. So we have to test it on a large number of patients.

00:29:00:24 – 00:29:19:05

We think that within five years that this could be available for people like Jenny, a cancer survivors and are worried about recurrence. And a few years later, it’ll be available for all women who have never had cancer but are worried that they may get cancer in the future.

00:29:20:00 – 00:29:30:12

Okay. And then we’ve we’ve talked to all about the rosy ness and the loveliness, a potential, the dangers that you can think of. Well.

00:29:31:02 – 00:29:55:20

We haven’t seen anything really bad yet. We did increase doses in the research process. We increased doses. And we got to a point where, again, there were no major systemic issues, no organ function issues or anything like that. But we did start seeing even more irritation at the site of injection. And so we stepped back on the dose from that.

00:29:55:20 – 00:30:23:00

And and yet still women are having a good immune response. The dangers are really in in the statistics. I mean, every woman who’s who’s being who gets this vaccine administered is a human being. But we have to look at the statistics. We have to be able to test this in thousands of women and see if there are a small percentage of women that have serious side effects.

00:30:23:00 – 00:30:48:09

So far, none have. But we’ve tested in 15. When we tested in 10,000, will there be, you know, one in 10,000 women that have a bad side effect? And if it is one in 10,000, you can do the math. And when we test when we treat a billion women across the world with this vaccine, if one in 10,000 has a bad side effect, you know, you can calculate the numbers.

00:30:48:24 – 00:31:05:13

You know, it’s it’s so it’s so that’s that’s the one thing that we and the FDA are always going to be looking at is, you know, what are the side effects? And fingers crossed so far we haven’t seen anything. But you know, we have to test it in a larger number of women.

00:31:05:22 – 00:31:10:21

Okay. And do you foresee this kind of technology being applied to other types of cancers?

00:31:11:12 – 00:31:38:24

Yes, absolutely. In fact, if this shows success in the large number of women that we’re talking about, then we anticipate cancer research is going to completely change and we’re going to start looking for these so-called retired proteins in other types of cancer. In fact, along with the Cleveland Clinic, we are also working on an ovarian cancer vaccine similar to the breast cancer vaccine.

00:31:39:16 – 00:32:03:11

That vaccine is still in animal testing phase right now, and we hope to bring it out into human testing within the next 18 months or so. And so, yeah, absolutely. We’d like to eliminate breast cancer and ovarian cancer. We’re starting to think about other types of cancer as well. Those are the two for which we have done the most research, which I should say the Cleveland Clinic has been the most research.

00:32:03:20 – 00:32:12:03

And as we go forward, assuming everything is looking good with the breast cancer vaccine, it just makes sense that we do this for other types of cancer as well.

00:32:12:21 – 00:32:32:20

Very good. Okay. So we have actually done 10 minutes before our allotted time. So kudos to everyone. We got to go have lunch or whatever we’re doing earlier. Anything else that either of you want to say? This is going to go out to the to the world. So anything you’d like to say before we end off either of you?

00:32:33:11 – 00:32:59:05

Yeah, I’d like to just say one thing. The number of women that we’re going to have to test this on is going to be large eventually. Right now, the trial is only at the Cleveland Clinic, and you wouldn’t believe the number of people that call me asking me if they can take this vaccine. Unfortunately, they would have to be in Cleveland and be able to go to the Cleveland Clinic for for participation in the trial.

00:32:59:14 – 00:33:29:10

Eventually, we’re going to do the phase two, and the phase three will be at multiple sites throughout the country. And even internationally. And so I would love to encourage people to keep track of the company. We do press releases when we expand the trials. And, you know, we excuse me for that and we anticipate that, you know, the challenge always is there is the recruiting people to be participants in the trials.

00:33:29:10 – 00:33:57:04

So if people are interested, you know, just please, please, please keep track of us. Our website is WWW.ANIXA.COM. Our stock symbol is ANIX and you actually can go on Yahoo Finance look it up and then from there go to the website and look you know not even go to the website. You can look at the press releases that we issue at on the financial sites and and just stay abreast or excuse the time it’s going to what we’re what we’re working on.

00:33:59:00 – 00:34:01:11

Everyone one okay And Jennifer, any last words?

00:34:02:24 – 00:34:06:06

I don’t think so. I think I covered it, but thank you so much.

Revolutionizing Breast Cancer Prevention: The Promising Vaccine Journey | Exclusive Interview

Leave a Comment Cancel Reply